ClinicalTrials.gg
CompletedNCT04283045CAITUpdated Nov 10, 2026Results posted

Community-based Adaptive Autism Intervention for Toddlers

An interventional study of JASPER and JASPER Plus+ in Autism Spectrum Disorder, sponsored by University of California, Los Angeles. Completed at 1 site in United States. Open to participants aged 24 Months to 36 Months. Per ClinicalTrials.gov, last updated 2026-11-10.

Primary conditionAutistic DisorderRegistry: Autism Spectrum DisorderReclassifiedWhy we changed it
Registry
Autism Spectrum Disorder — the first condition term the registry derived for this study.
ClinicalTrials.gg
Autistic Disorder
Why
  1. The study's listed conditions name Autistic Disorder, a narrower term within Autism Spectrum Disorder.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Treatment

How we know

Updated Nov 10, 2026Results postedStudy documents posted+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
201
Allocation
Randomized
Ages
24 Months to 36 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 20 studies in Autistic Disorder by University of California, Los Angeles — 3 open to participants now, 6 under way, none of them phase 3. Autistic Disorder · University of California, Los Angeles.

Enrollment
3rd of 20
201 · median 92
Started
2020
the only one that year
No phase
18 of 20
3 open now
Registered
16th of 20
by date

Among the 20 studies in Autistic Disorder by University of California, Los Angeles, this one is the 3rd largest by enrollment, is the only one that started in 2020, is one of 18 with no phase, and was the 16th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

3 of the 20 studies in Autistic Disorder by University of California, Los Angeles are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 24 Months to 36 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Autistic Disorder by University of California, Los Angeles, or all of them as a file.
02

Study summary

The proposed study (CAIT: Community-based Adaptive Autism Intervention for Toddlers) aims to determine the most optimal sequence of interventions for improving the social- communicative, language and cognitive outcomes of toddlers with autism spectrum disorder (ASD). The target population consists of 2-3 year-old children with ASD who receive community based, publicly funded early intervention in two authentic educational settings in East Harlem and the Bronx, NY known as New York Center for Infants \& Toddlers (NYCIT). An expected 300 toddlers with ASD will participate with their community-recruited paraprofessional teaching assistants (TAs) and group leaders (GLs). The study aims to construct the most effective one-year, two-phase, adaptive intervention, in which intervention is individualized based on a child's initial response to intervention. Phase 1, from program entry to either 6 or 12 weeks (randomized), involves 60 minutes daily of an evidence based social communication intervention, JASPER (Joint Attention, Symbolic Play, Engagement \& Regulation) delivered 1-on-1 to the child by the trained TA. At end of Phase 1, response to intervention is rated by the GLs for slow or fast improvements of joint engagement (a core deficit in the early development of children with ASD, and a significant indicator of good progress toward improving social communication and language). In Phase 2 (to week 24), toddlers responding slowly are re-randomized to continue with JASPER for 60 minutes per day or augment treatment with direct, structured teaching of social communication targets for 30 minutes and JASPER for another 30 minutes per day. Toddlers responding quickly are given 30 minutes of JASPER and 30 minutes of jasPEER (JASPER with a peer) to further improve socialization and social communication.

Read the detailed description

This study will use a Sequential Multiple Assignment Randomized Trial (SMART) design to assess when to examine initial response to treatment, as well as whether and how best to augment the current first line, standard of care intervention for children demonstrating a slower response.

First, at program entry, the investigators will assess all toddlers using both standardized and experimental assessments as they enroll in the NYCIT program. After entry assessments, the investigators will randomize each child with equal probability to early response assessment at either six weeks or 12 weeks (timing). This early response assessment will be used to determine whether children are considered fast or slow responders to treatment. Children who are considered early responders will continue to receive JASPER. Children responding slowly to the initial intervention will be randomized to continue JASPER or to add JASPER Plus+ to their JASPER sessions. Approximately 200-300 toddlers (24-36 months) with a diagnosis of ASD, as confirmed by clinical evaluation records required for placement at the NYCIT will participate. Children will be assessed prior to intervention, immediately after Stage 1(early response) at either six or twelve weeks, exit Stage 2 intervention, and follow up.

If teacher/paraprofessional withdraws from the study, all reasonable efforts will be made to place the child with another consenting teacher/paraprofessional. Based on the first two years of trials working with this center, no teacher withdrew mid study. However, a small number of teachers did change positions or took leave (e.g., maternity leave, move for job in another district). In these cases, the child was transferred to another consenting teacher.

SMART Design:

Initial Randomize to Stage 1 Treatment

Stage 1: JASPER (6 weeks)

Early Responders/Slow Responders determined

Stage 2: JASPER (Early Responders only)-A

Slow Responders randomized to Stage 2: JASPER Plus+ + JASPER -B or Stage 2: JASPER (Randomized for slow responders)-C A, B, and C options occur during the following 18 weeks

Exit assessments and Follow up assessments at 3 months post exit

Initial Randomized to Stage 1 Treatment

Stage 1: JASPER (12 weeks)

Early Responders/Slow Responders determined

Stage 2: JASPER (Early Responders only)- D Slow Responders randomized to Stage 2: JASPER Plus+ + JASPER - E or Stage 2: JASPER (Randomized for slow responders)- F D, E, and F options occur during the following 12 weeks

03

Conditions studied

  • Autism Spectrum Disorder

Browse trials for

Keywords

  • ASD
  • autism
  • JASPER
  • JASPER Plus+
04

In context

Autistic Disorder Reclassified

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

This study's enrollment of 201 is above the median of 50 across 814 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,172 studies on the registry; 195 are open to participants now.

Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.

Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
24 Months to 36 Months
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Child Inclusion Criteria:

  • diagnosis of ASD based on clinical report or ADOS-2 if needed
  • chronological age less than 36 months
  • caregiver consent to learn intervention strategies if randomized to either parent condition.

Exclusion Criteria:

  • Child has co-morbid disorders such as cerebral palsy or down syndrome.
06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
201 participants (actual)

Study arms

  • Active comparator
    JASPER (6 Weeks) + Responder + JASPER

    Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 6 weeks. If child is an early responder, he/she will continue to do JASPER daily, 5 times a week, for the remaining 18 weeks of the study.

    Behavioral: JASPER

  • Active comparator
    JASPER (6 Weeks) + Slow Responder + JASPER

    Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 6 weeks. If child is a slow responder, he/she will continue to do JASPER daily, 5 times a week, for the remaining 18 weeks of the study.

    Behavioral: JASPER

  • Active comparator
    JASPER (6 Weeks) + Slow Responder + JASPER Plus

    Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 6 weeks. If child is a slow responder, he/she can get randomized to receive 30 minutes of JASPER Plus+ and 30 minutes of JASPER with a TA daily, 5 days a week for the remaining 18 weeks of the study.

    Behavioral: JASPER · Behavioral: JASPER Plus+

  • Active comparator
    JASPER (12 Weeks) + Responder + JASPER

    Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 12 weeks. If child is an early responder, he/she will do JASPER for 60 minutes with TA, 5 times a week, for the remaining 12 weeks of the study.

    Behavioral: JASPER

  • Active comparator
    JASPER (12 Weeks) + Slow Responder + JASPER

    Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 12 weeks. If child is a slow responder, he/she can get randomized to continue his/her daily sessions of JASPER with the TA for an hour each day, 5 days a week for the following 12 weeks of the study.

    Behavioral: JASPER

  • Active comparator
    JASPER (12 Weeks) + Slow Responder + JASPER Plus

    Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 12 weeks. If child is a slow responder, he/she can get randomized to receive 30 minutes of JASPER Plus+ and 30 minutes of JASPER with a TA daily, 5 days a week for the remaining 12 weeks of the study.

    Behavioral: JASPER · Behavioral: JASPER Plus+

Interventions

  • BehavioralJASPER

    JASPER is a developmentally anchored behavioral intervention that assumes that communication develops from social interactions in which specific social engagement strategies, symbolic representations, and early communication forms are modeled and naturally reinforced by the adult's responses to the child. The adult referred in this condition is the TA.

  • BehavioralJASPER Plus+

    JASPER Plus+ refers to direct instruction of social communication targets of pointing to share, showing gesures, and give to share gestures, and play targets at the child's target play level. JASPER Plus+ will occur at a table top with repeated trials of instruction until the child can produce the desired behavior on their own.

07

What researchers measure

Primary outcomes

  1. Social Communicative Utterances (SCU)

    SCUs are unprompted, generative (nonscripted) verbal utterances that are directed to a partner for the purpose of sharing information (comment) or making a request during a 15 minute assessment

    Time frame: Baseline, Week 6, Week 12, and Week 24

Secondary outcomes

  1. Play Levels/Types Using the Short Play and Communication Evaluation (SPACE)-Longitudinal

    The total number of play types were coded from the 16 levels of play that ranged from indiscriminate to thematic play.

    Time frame: baseline, exit

  2. Joint Engagement-longitudinal

    Proportion of time children and adult actively focus on shared objects/events

    Time frame: baseline, exit

08

Results

Posted Oct 9, 2026
Limitations and caveats
The study started during 2020 and was put on hold during COVID lockdowns. Once lockdown was lifted site protocols were modified due to COVID restrictions. As a result the research protocol was modified to account for reduced numbers of children in class, and inability to put children together in peer dyads. The original design was modified to account for these changes such that children who were early responders to initial JASPER continued to receive one on one JASPER in stage 2.

Participant flow

NYCIT is an approved provider of publicly funded early intervention services to children living in Manhattan and the Bronx. Centers are located in East Harlem and the Bronx to provide access for families with low resources. Children who are identified with ASD by New York State Early Intervention Services Coordinators are referred to NYCIT.

Stage 1 (Baseline to Early Response)
Participant flow — Stage 1 (Baseline to Early Response)
MilestoneJASPER (6 Weeks) + Responder + JASPERJASPER (6 Weeks) + Slow Responders + JASPERJASPER (6 Weeks) + Slow Responders + JASPER PlusJASPER (12 Weeks) + Responder + JASPERJASPER (12 Weeks) + Slow Responders + JASPERJASPER (12 Weeks) + Slow Responders + JASPER Plus
Started213938243837
Completed213935243337
Not completed003050
Stage 2 (Early Response to Exit)
Participant flow — Stage 2 (Early Response to Exit)
MilestoneJASPER (6 Weeks) + Responder + JASPERJASPER (6 Weeks) + Slow Responders + JASPERJASPER (6 Weeks) + Slow Responders + JASPER PlusJASPER (12 Weeks) + Responder + JASPERJASPER (12 Weeks) + Slow Responders + JASPERJASPER (12 Weeks) + Slow Responders + JASPER Plus
Started213935243337
Completed193229223034
Not completed276233

Outcome measures

PrimarySocial Communicative Utterances (SCU)

SCUs are unprompted, generative (nonscripted) verbal utterances that are directed to a partner for the purpose of sharing information (comment) or making a request during a 15 minute assessment

Time frame:
Baseline, Week 6, Week 12, and Week 24
Reported as:
Mean · Utterances and Gestures
Social Communicative Utterances (SCU)
Utterances and GesturesJASPER (6 Weeks)JASPER (12 Weeks)
Baseline14.06 ± 13.0413.39 ± 10.78
Week 616.92 ± 12.5216.19 ± 16.49
Week 1216.16 ± 12.0918.20 ± 14.42
Week 2417.81 ± 12.6518.16 ± 15.82
SecondaryPlay Levels/Types Using the Short Play and Communication Evaluation (SPACE)-Longitudinal

The total number of play types were coded from the 16 levels of play that ranged from indiscriminate to thematic play.

Time frame:
baseline, exit

Results for this outcome have not been posted.

SecondaryJoint Engagement-longitudinal

Proportion of time children and adult actively focus on shared objects/events

Time frame:
baseline, exit

Results for this outcome have not been posted.

Adverse events

Collected over Baseline to End of Study (24 weeks). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
JASPER (6 Weeks) + Responder + JASPER0/21 (0%)0/21 (0%)0/21 (0%)
JASPER (6 Weeks) + Slow Responders + JASPER0/39 (0%)0/39 (0%)0/39 (0%)
JASPER (6 Weeks) + Slow Responders + JASPER Plus0/35 (0%)0/35 (0%)0/35 (0%)
JASPER (12 Weeks) + Responder + JASPER0/24 (0%)0/24 (0%)0/24 (0%)
JASPER (12 Weeks) + Slow Responders + JASPER0/33 (0%)0/33 (0%)0/33 (0%)
JASPER (12 Weeks) + Slow Responders + JASPER Plus0/37 (0%)0/37 (0%)0/37 (0%)

Baseline characteristics

Baseline Characteristics were not collected for Parents

Age, Continuous
Age, Continuous(month)JASPER (6 Weeks)JASPER (12 Weeks)Total
Mean31.23 ± 3.530.63 ± 4.230.93 ± 3.87
Sex: Female, Male
Sex: Female, Male(Participants)JASPER (6 Weeks)JASPER (12 Weeks)Total
Female343670
Male6463127
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)JASPER (6 Weeks)JASPER (12 Weeks)Total
Hispanic or Latino443983
Not Hispanic or Latino5460114
Unknown or Not Reported000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)JASPER (6 Weeks)JASPER (12 Weeks)Total
Caucasian/White181533
African American384583
Asian538
Multi-Racial6612
Other/Unknown313061
Child Initiated Joint Engagement
Child Initiated Joint Engagement(Proportion)JASPER (6 Weeks)JASPER (12 Weeks)Total
Mean0.23 ± 0.220.23 ± 0.230.23 ± 0.23
09

Study locations

1 site
  • New York Center for Infants and Toddlers, Inc.
    New York, New York 10027, United States
10

References and documents

Publications

  • Shire SY, Shih W, Chang YC, Kodjoe M, Nodzo S, Kasari C. Comparing the Implementation Context for Early Intervention Services Before and During the COVID-19 Pandemic. Prev Sci. 2026 Jan;27(1):96-106. doi: 10.1007/s11121-024-01696-5. Epub 2024 Jun 11. PubMed 38862831 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

11

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2020 to primary completion in Dec 2024, 48 months.

Results were first posted in Oct 2026, 1 year 9 months after primary completion.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's 48 months is above that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2020
First posted
Feb 25, 2020
StartActual
Dec 3, 2020
Primary completionActual
Dec 31, 2024
CompletionActual
Dec 31, 2024
Results first posted
Oct 9, 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted, then revised
posted Oct 9, 2026 · revised Nov 10, 2026
Enrollment
199→201
Oct 9, 2026
Interventions
Arm changed JASPER (6 weeks)→JASPER (6 Weeks) + Responder + JASPER; JASPER (12 weeks)→JASPER (12 Weeks) + Responder + JASPER. Arms added: JASPER (6 Weeks) + Slow Responder + JASPER·JASPER (6 Weeks) + Slow Responder + JASPER Plus·JASPER (12 Weeks) + Slow Responder + JASPER·JASPER (12 Weeks) + Slow Responder + JASPER Plus
Oct 9, 2026
Primary outcomes
1 edited, 7 removed
What changed in the outcomes
  • EditedChange in social communicative utterancesSocial Communicative Utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: entry (1st month of study) and 6 weeks after entry → Baseline, Week 6, Week 12, and Week 24
  • RemovedChange in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: 6 weeks after entry and 12 weeks after entry
  • RemovedChange in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: 12 weeks after entry and 24 weeks after entry
  • RemovedChange in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
  • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: entry (1st month of study) and 6 weeks after entry
  • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 6 weeks after entry and 12 weeks after entry
  • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 12 weeks after entry and 24 weeks after entry
  • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
Oct 9, 2026
Secondary outcomes
1 edited, 1 added, 7 removed
What changed in the outcomes
  • EditedChange in play levels/types usingPlay Levels/Types Using the Short Play and Communication Evaluation (SPACE)-LongitudinalTime frame: entry (1st month of study) and 6 weeks after entry → baseline, exit
  • AddedJoint Engagement-longitudinalTime frame: baseline, exit
  • RemovedChange in play levels/types using the Short Play and Communication Evaluation (SPACE)Time frame: 6 weeks after entry and 12 weeks after entry
  • RemovedChange in play levels/types using the Short Play and Communication Evaluation (SPACE)Time frame: 12 weeks after entry and 24 weeks after entry
  • RemovedChange in play levels/types using the Short Play and Communication Evaluation (SPACE)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
  • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: entry (1st month of study) and 6 weeks after entry
  • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 6 weeks after entry and 12 weeks after entry
  • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 12 weeks after entry and 24 weeks after entry
  • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
Oct 9, 2026
Show all 2 updates
  1. Nov 10, 2026
    Posted results revised
    + 1 other change: verification date
  2. Oct 9, 2026
    Results posted
    Enrollment 199→201
    Primary outcomes 1 edited, 7 removed
    What changed in the outcomes
    • EditedChange in social communicative utterancesSocial Communicative Utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: entry (1st month of study) and 6 weeks after entry → Baseline, Week 6, Week 12, and Week 24
    • RemovedChange in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: 6 weeks after entry and 12 weeks after entry
    • RemovedChange in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: 12 weeks after entry and 24 weeks after entry
    • RemovedChange in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
    • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: entry (1st month of study) and 6 weeks after entry
    • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 6 weeks after entry and 12 weeks after entry
    • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 12 weeks after entry and 24 weeks after entry
    • RemovedChange in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
    Secondary outcomes 1 edited, 1 added, 7 removed
    What changed in the outcomes
    • EditedChange in play levels/types usingPlay Levels/Types Using the Short Play and Communication Evaluation (SPACE)-LongitudinalTime frame: entry (1st month of study) and 6 weeks after entry → baseline, exit
    • AddedJoint Engagement-longitudinalTime frame: baseline, exit
    • RemovedChange in play levels/types using the Short Play and Communication Evaluation (SPACE)Time frame: 6 weeks after entry and 12 weeks after entry
    • RemovedChange in play levels/types using the Short Play and Communication Evaluation (SPACE)Time frame: 12 weeks after entry and 24 weeks after entry
    • RemovedChange in play levels/types using the Short Play and Communication Evaluation (SPACE)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
    • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: entry (1st month of study) and 6 weeks after entry
    • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 6 weeks after entry and 12 weeks after entry
    • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 12 weeks after entry and 24 weeks after entry
    • RemovedChange in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)Time frame: 24 weeks after entry and 3 months after intervention (36 weeks)
    Interventions Arm changed JASPER (6 weeks)→JASPER (6 Weeks) + Responder + JASPER; JASPER (12 weeks)→JASPER (12 Weeks) + Responder + JASPER. Arms added: JASPER (6 Weeks) + Slow Responder + JASPER·JASPER (6 Weeks) + Slow Responder + JASPER Plus·JASPER (12 Weeks) + Slow Responder + JASPER·JASPER (12 Weeks) + Slow Responder + JASPER Plus
    + 3 other changes: index terms, verification date and registry notes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

12

Registry details

Key details

Study ID
NCT04283045
Responsible party
Connie Kasari, Ph.D. (Professor/PhD, University of California, Los Angeles) — Principal investigator
First posted
Feb 25, 2020
Start date
Dec 3, 2020
Primary completion
Dec 31, 2024
Completion
Dec 31, 2024
Results posted
Oct 9, 2026
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion